MSB 5.24% $1.11 mesoblast limited

Ann: Trading Halt, page-376

  1. 1,889 Posts.
    lightbulb Created with Sketch. 358
    All reasonable point outs, but i would urge you and others frustrated to chill and think about the LT game here.

    whether the FDA rules favourably on Ryoncil today, last month, next month doesnt really affect the outlook for 2_3 years time, as long as they approve of course.

    MSO will get a bump in the SP on positive news and the traders and speculators will be happy, but its the long term investors who believe in the business model and management team to execute, grow the pipeline and sales and as long as we have access to the US market, it will take a few years for the fruits to shine from the hooeful FDA approval. it is this time, when the fruit is shining bright, that MSO will be many times more valuable than any ST bump the STerms are looking for here.

    just relax and enjoy being part of a revolutionary medical company that will imo , make any LT investor much more wealthy than they would ever expect.

    gltah
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.